Morningstar Advisor - April/May 2010 - 63
Teva to buy Barr for $7.46 billion, boost generic lead | Reuters
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Lettres persanes 2.0 Réécriture du roman épistolaire de M...
Investing Insights - Podcast Addict
TEVA Institutional Ownership - Teva Pharmaceutical Industries Ltd. Stock
Teva debuts generics of Delzicol and Tarceva in the USA
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Lax Opioid Settlements Helped Boost This Drugmaker's Stock
Teva Shares Undervalued Despite Opioid Case | Morningstar
Teva, Sun Pharma to pay $2.15 billion to settle Pfizer patent suit | Reuters
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Morningstar Advisor - June/July 2012 - 46
Morningstar Advisor - June/July 2012 - 46
2 Undervalued Stocks Among Berkshire's Latest Buys | Morningstar
Argus Downgrades Teva Pharmaceutical Industries to Hold From Buy | MarketScreener
TEVJF Institutional Ownership - Teva Pharmaceutical Industries Ltd. Stock
Teva Bonds: 8.8% Yield To Maturity Understates Upside (NYSE:TEVA) | Seeking Alpha
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Teva Pharmaceuticals USA - ZIP 45213, NAICS 523930
Generic Manufacturers Find Their New Medicine | Morningstar
Teva Bonds: 8.8% Yield To Maturity Understates Upside (NYSE:TEVA) | Seeking Alpha
3 Undervalued Warren Buffett Stocks | Morningstar
Drugmakers Delving Into Multiple Sclerosis Market | Morningstar
